Clearance of bone marrow mast cells after hypomethylating agent and venetoclax for systemic mastocytosis associated with myeloid neoplasia

Systemic mastocytosis (SM) results from clonal proliferation of neoplastic mast cells that infiltrate bone marrow and other organs. A major subset of patients with SM has a clonally related myeloid neoplasm and the SM itself (SM‐AMN). We evaluated the efficacy of hypomethylating agent and venetoclax...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourhassan, Hoda, Kim, Young, Pullarkat, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099671/
https://www.ncbi.nlm.nih.gov/pubmed/36335580
http://dx.doi.org/10.1111/ejh.13894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099671/
https://www.ncbi.nlm.nih.gov/pubmed/36335580
http://dx.doi.org/10.1111/ejh.13894

Ejemplares similares